Chief Operating Officer overseeing operational leadership and vendor management in drug development for Antaros Tracer. Drive strategic growth while ensuring compliance in clinical studies.
Responsibilities
Act as “second-in-command” to the CEO, actively contributing to building and developing the company
Drive the implementation of company systems and processes (e.g. QMS, SharePoint, website) in collaboration with QA
Project management for all CMC- and tox-related aspects of pre-clinical and clinical studies.
Plan, manage, and ensure delivery of tasks in line with SOPs, timelines, and quality requirements
Serve as primary point of contact with sponsors, CROs, vendors, and regulatory authorities
Prepare and support regulatory and ethics submissions, including CMC documentation
Manage project budgets and contribute to sponsor proposals
Lead proactive vendor management for PET-tracer precursor manufacturers and other providers (toxicology CROs, PET centers, storage facilities)
Establish agreements, oversee stability studies, and manage supply to ongoing projects
Conduct vendor qualification and perform vendor oversight in collaboration with QA
Manage associated budgets
Identify and monitor potential risks, maintain risk management logs, and develop contingency plans
Participate in senior management interactions (e.g. our Board) as required.
Requirements
University degree in life sciences, pharmacy, chemistry, or related field.
Extensive experience of project management of CMC- and tox-related activities for pre-clinical (animal models and tox) and/or clinical studies
Experience with regulatory submissions and interactions in support of clinical trial applications
Strong leadership skills and ability to work strategically as well as operationally
Extensive experience of operating in and complying with GMP and GLP regulations
Have business acumen and experience of contractual negotiations
Proven track record of vendor qualification and management
Experience in radiochemistry, PET-tracer or radiopharmaceuticals development
Experience of operating in other quality controlled environments such as GCP, GDP, and GDocP
Benefits
Hybrid work environment
Opportunity to make a real impact in drug development
Chief Operating Officer leading operations for BURGA, a fast - scaling e - commerce brand. Driving operational excellence and team collaboration as the company expands globally.
Bras droit de CEO/COO at Neosilver supporting operational and strategic initiatives. Collaborating across teams to enhance business development and administrative functions.
Chief Operating Officer overseeing operational strategies and multi - campus performance for creative education institution. Leading transformation and building operational excellence across various departments.
Risk Control Partner empowering teams to navigate risk and foster improvement at Rabobank. Guiding operational integration of risk management within the organization to achieve compliance and cultural ownership.
COO of Internal Audit providing operational leadership for a major financial group. Ensuring high - performance and transformation of Internal Audit processes.
Chief Operating Officer at Telos Health Systems responsible for operational excellence and national growth. Leading multi - site healthcare operations and ensuring high - quality clinical delivery.
COO overseeing operational activities within railway maintenance for Eleda Rail in Sweden. Leading quality assurance and operational development initiatives to support business growth.
Deputy COO supporting growth and operational transformation in defence and security. Overseeing initiatives across engineering, production, and supply chain with a global focus.
Executive Assistant to COO working closely with management on strategic topics. Supporting administrative and organizational tasks in a dynamic, hybrid environment at an international company.
Analytical role supporting COO Office in a global financial services company. Focus on strategy development, project execution, and collaboration with top management.